Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Feasibility and Benefit of Molecularly-Informed Enrollment into Early Phase Clinical Trials for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 4110.

https://doi.org/10.1182/blood-2018-99-110852

Published: 2018

Journal Articles

Non-Effectiveness of Using RICE Post RDHAP or RDHAP Post RICE after Failure of First Line Salvage Therapy in DLBCL Patients Who Are Eligible for ASCT

Tony Ibrahim, MD MSc, Tarek Assi, Julien Lazarovici, MD, Maxime Annereau, PharmD, David Ghez, MD PhD, Jean-Marie Michot, MD, Julia Arfi-Rouche, Julien Rossignol, MD PhD, Veronique Vergé, Jacques Bosq, Peggy Dartigues-Cuillères, MD, Alina Danu, MD, Vincent Ribrag, MD

Blood (2018) 132 (Supplement 1): 4226.

https://doi.org/10.1182/blood-2018-99-117444

Published: 2018

Journal Articles

Strong Expression of the Immune Checkpoint Regulators LAG3 and Tim3 in Hodgkin Lymphoma

Layal el Halabi, Julien Adam, Virginie Marty, Jacques Bosq, MD, Julien Lazarovici, MD, Alina Danu, MD, Vincent Ribrag, MD, David Ghez, PhD MD

Blood (2016) 128 (22): 2952.

https://doi.org/10.1182/blood.V128.22.2952.2952

Published: 2016

Journal Articles

Serum 2-Hydroxyglutarate Level Can Predict IDH2 Mutation in Myeloid Sarcoma

Christophe Willekens, MD, Jean-Baptiste Micol, MD, Vianney Poinsignon, Cyril Quivoron, Véronique Saada, Sophie Broutin, Marie Terroir-Cassou-Mounat, David Ghez, Jean-Henri Bourhis, MD PhD, Jacques Bosq, MD, Vincent Ribrag, MD, Angelo Paci, Virginie Lacronique-Penard, Stéphane De Botton

Blood (2015) 126 (23): 3835.

https://doi.org/10.1182/blood.V126.23.3835.3835

Published: 2015

Journal Articles

Concurrent Radiation and ESHAP Regimen in Localized Extranodal NK/T-Cell Lymphoma Nasal Type, Phase II French Study

Jean-Marie Michot, MD, Theodore Girinsky, MD, Alina Danu, MD, Anna Antosikova, Christophe Ferme, MD, Julien Lazarovici, MD, Christophe Willekens, Ali N Chamseddine, MD, David Ghez, MD PhD, Camille Bigenwald, Jacques Bosq, MD, Stephane de Botton, Renaud Mazeron, MD, Vincent Ribrag, MD

Blood (2014) 124 (21): 1707.

https://doi.org/10.1182/blood.V124.21.1707.1707

Published: 2014

Journal Articles

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

Vincent Ribrag, MD, Serge Koscielny, ph.D., Krimo Bouabdallah, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Gilles Salles, MD, Olivier Casasnovas, Christian Recher, MD, Remy Gressin, MD, Jérome Cornillon, M.D., Raoul Herbrecht, MD, Sylviane Iacobelli, Jacques Bosq, M.D., Bertrand Coiffier, MD, PhD

Blood (2012) 120 (21): 685.

https://doi.org/10.1182/blood.V120.21.685.685

Published: 2012

Journal Articles

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets

Marion Travert, Yenlin Huang, Laurence de Leval, Nadine Martin-Garcia, Marie-Helene Delfau-Larue, Françoise Berger, Jacques Bosq, Josette Brière, Jean Soulier, Elizabeth MacIntyre, Teresa Marafioti, Aurélien de Reyniès, Philippe Gaulard

Blood (2012) 119 (24): 5795–5806.

https://doi.org/10.1182/blood-2011-12-396150

Published: 2012

Includes: Supplemental data

Journal Articles

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

Yenlin Huang, Aurélien de Reyniès, Laurence de Leval, Bouchra Ghazi, Nadine Martin-Garcia, Marion Travert, Jacques Bosq, Josette Brière, Barbara Petit, Emilie Thomas, Paul Coppo, Teresa Marafioti, Jean-François Emile, Marie-Hélène Delfau-Larue, Christian Schmitt, Philippe Gaulard

Blood (2010) 115 (6): 1226–1237.

https://doi.org/10.1182/blood-2009-05-221275

Published: 2010

Includes: Supplemental data

Journal Articles

Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis

Magda Pinyol, Silvia Bea, Laura Plà, Vincent Ribrag, Jacques Bosq, Andreas Rosenwald, Elias Campo, Pedro Jares

Blood (2007) 109 (12): 5422–5429.

https://doi.org/10.1182/blood-2006-11-057208

Published: 2007

Includes: Supplemental data

Journal Articles

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

Céline Bossard, Karim Belhadj, Felix Reyes, Nadine Martin-Garcia, Françoise Berger, Jean Alain Kummer, Josette Brière, Anne-Catherine Baglin, Stéphane Cheze, Jacques Bosq, Vincent Ribrag, Christian Gisselbrecht, Nicolas Mounier, Philippe Gaulard

Blood (2006) 109 (5): 2183–2189.

https://doi.org/10.1182/blood-2006-07-033142

Published: 2006

Journal Articles

Prognostic Significance of Immunohistochemical Markers in Classical Hodgkin Lymphoma Response to Treatment A Study of 59 Cases.

Danielle Canioni, MD, Benedicte Deau, MD, Pierre Taupin, MD, Jacques Bosq, MD, Vincent Ribrag, MD, Richard Delarue, MD, Viorel Vasiliu, MD, Nicole Brousse, MD, Olivier Hermine, MD, PhD

Blood (2005) 106 (11): 972.

https://doi.org/10.1182/blood.V106.11.972.972

Published: 2005

Journal Articles

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases

Blood (2000) 95 (7): 2212–2218.

https://doi.org/10.1182/blood.V95.7.2212

Published: 2000

Journal Articles

Nonhepatosplenic γδ T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization

Bertrand Arnulf, Christiane Copie-Bergman, Marie-Hélène Delfau-Larue, Anne Lavergne-Slove, Jacques Bosq, Janine Wechsler, Michel Wassef, Claude Matuchansky, Bernard Epardeau, Marc Stern, Martine Bagot, Felix Reyes, Philippe Gaulard

Blood (1998) 91 (5): 1723–1731.

https://doi.org/10.1182/blood.V91.5.1723

Published: 1998

NARROW

Feasibility and Benefit of Molecularly-Informed Enrollment into Early Phase Clinical Trials for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Non-Effectiveness of Using RICE Post RDHAP or RDHAP Post RICE after Failure of First Line Salvage Therapy in DLBCL Patients Who Are Eligible for ASCT

Strong Expression of the Immune Checkpoint Regulators LAG3 and Tim3 in Hodgkin Lymphoma

Serum 2-Hydroxyglutarate Level Can Predict IDH2 Mutation in Myeloid Sarcoma

Concurrent Radiation and ESHAP Regimen in Localized Extranodal NK/T-Cell Lymphoma Nasal Type, Phase II French Study

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

Prognostic Significance of Immunohistochemical Markers in Classical Hodgkin Lymphoma Response to Treatment A Study of 59 Cases.

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases

Nonhepatosplenic γδ T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only